Wellnex Secures TGA approval for Liquid Paracetamol plus Caffeine Soft Gel as it targets growth opportunities
Wellnex Life has achieved a key milestone with a new market authorisation by Australia’s Therapeutic...
![WNX [Page4 - Thumbnail]](https://wellnexlife.investorportal.com.au/wp-content/uploads/2025/01/WNX-Page4-Thumbnail-400x260.png "WNX [Page4 - Thumbnail]")
![WNX [Page 2 - Thumbnail]](https://wellnexlife.investorportal.com.au/wp-content/uploads/2025/01/WNX-Page-2-Thumbnail-400x260.png "WNX [Page 2 - Thumbnail]")
![WNX [Page 1 - Thumbnail]](https://wellnexlife.investorportal.com.au/wp-content/uploads/2025/01/WNX-Page-1-Thumbnail-400x260.png "WNX [Page 1 - Thumbnail]")
- A gross income of $250,000 or more per annum in each of the previous two financial years; or
- Net assets of at least $2.5 million; and
- A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)